|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schulze A and Harris AL: How cancer
metabolism is tuned for proliferation and vulnerable to disruption.
Nature. 491:364–373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parks SK, Chiche J and Pouysségur J:
Disrupting proton dynamics and energy metabolism for cancer
therapy. Nat Rev Cancer. 13:611–623. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng R, Yao Q, Xie G, Du S, Ren C, Wang Y
and Yuan Y: TAT-ODD-p53 enhances the radiosensitivity of hypoxic
breast cancer cells by inhibiting Parkin-mediated mitophagy.
Oncotarget. 6:17417–17429. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hamdan FH and Zihlif MA: Gene expression
alterations in chronic hypoxic MCF7 breast cancer cell line.
Genomics. 104:477–481. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soares RJ, Cagnin S, Chemello F,
Silvestrin M, Musaro A, De Pitta C, Lanfranchi G and Sandri M:
Involvement of microRNAs in the regulation of muscle wasting during
catabolic conditions. J Biol Chem. 289:21909–21925. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Godnic I, Zorc M, Jevsinek Skok D, Calin
GA, Horvat S, Dovc P, Kovac M and Kunej T: Genome-wide and
species-wide in silico screening for intragenic MicroRNAs in human,
mouse and chicken. PLoS One. 8:e651652013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gromak N, Dienstbier M, Macias S, Plass M,
Eyras E, Cáceres JF and Proudfoot NJ: Drosha regulates gene
expression independently of RNA cleavage function. Cell Rep.
5:1499–1510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhai H, Chen QJ, Chen BD, Yang YN, Ma YT,
Li XM, Liu F, Yu ZX, Xiang Y, Liao W, et al: Long noncoding RNA
MALAT1 as a putative biomarker of lymph node metastasis: A
meta-analysis. Int J Clin Exp Med. 8:7648–7654. 2015.PubMed/NCBI
|
|
10
|
Nagpal N, Ahmad HM, Chameettachal S,
Sundar D, Ghosh S and Kulshreshtha R: HIF-inducible miR-191
promotes migration in breast cancer through complex regulation of
TGFβ-signaling in hypoxic microenvironment. Sci Rep. 5:96502015.
View Article : Google Scholar
|
|
11
|
Chen W, Cai F, Zhang B, Barekati Z and
Zhong XY: The level of circulating miRNA-10b and miRNA-373 in
detecting lymph node metastasis of breast cancer: Potential
biomarkers. Tumour Biol. 34:455–462. 2013. View Article : Google Scholar
|
|
12
|
Du M, Shi D, Yuan L, Li P, Chu H, Qin C,
Yin C, Zhang Z and Wang M: Circulating miR-497 and miR-663b in
plasma are potential novel biomarkers for bladder cancer. Sci Rep.
5:104372015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei C, Luo Q, Sun X, Li D, Song H, Li X,
Song J, Hua K and Fang L: microRNA-497 induces cell apoptosis by
negatively regulating Bcl-2 protein expression at the
posttranscriptional level in human breast cancer. Int J Clin Exp
Pathol. 8:7729–7739. 2015.PubMed/NCBI
|
|
14
|
Troppan K, Wenzl K, Pichler M, Pursche B,
Schwarzenbacher D, Feichtinger J, Thallinger GG, Beham-Schmid C,
Neumeister P and Deutsch A: miR-199a and miR-497 are associated
with better overall survival due to increased chemosensitivity in
diffuse large B-cell lymphoma patients. Int J Mol Sci.
16:18077–18095. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han Z, Zhang Y, Yang Q, Liu B, Wu J, Zhang
Y, Yang C and Jiang Y: miR-497 and miR-34a retard lung cancer
growth by co-inhibiting cyclin E1 (CCNE1). Oncotarget.
6:13149–13163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng L, Liu A, Shen Y, Xu HZ, Yang SZ,
Ying XZ, Liao W, Liu HX, Lin ZQ, Chen QY, et al: Antitumor and
anti-angiogenesis effects of thymoquinone on osteosarcoma through
the NF-κB pathway. Oncol Rep. 29:571–578. 2013.
|
|
17
|
Howell A, Anderson AS, Clarke RB, Duffy
SW, Evans DG, Garcia-Closas M, Gescher AJ, Key TJ, Saxton JM and
Harvie MN: Risk determination and prevention of breast cancer.
Breast Cancer Res. 16:4462014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rinck A, Preusse M, Laggerbauer B, Lickert
H, Engelhardt S and Theis FJ: The human transcriptome is enriched
for miRNA-binding sites located in cooperativity-permitting
distance. RNA Biol. 10:1125–1135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Raychaudhuri S: MicroRNAs overexpressed in
growth-restricted rat skeletal muscles regulate the glucose
transport in cell culture targeting central TGF-β factor SMAD4.
PLoS One. 7:e345962012. View Article : Google Scholar
|
|
20
|
Luo Q, Li X, Gao Y, Long Y, Chen L, Huang
Y and Fang L: MiRNA-497 regulates cell growth and invasion by
targeting cyclin E1 in breast cancer. Cancer Cell Int. 13:952013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Y, Wondimu A, Yan S, Bobb D and
Ladisch S: Tumor gangliosides accelerate murine tumor angiogenesis.
Angiogenesis. 17:563–571. 2014. View Article : Google Scholar :
|
|
22
|
Retsky M, Bonadonna G, Demicheli R,
Folkman J, Hrushesky W and Valagussa P: Hypothesis: Induced
angiogenesis after surgery in premenopausal node-positive breast
cancer patients is a major underlying reason why adjuvant
chemotherapy works particularly well for those patients. Breast
Cancer Res. 6:R372–R374. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma J, Zhang L, Ru GQ, Zhao ZS and Xu WJ:
Upregulation of hypoxia inducible factor 1α mRNA is associated with
elevated vascular endothelial growth factor expression and
excessive angiogenesis and predicts a poor prognosis in gastric
carcinoma. World J Gastroenterol. 13:1680–1686. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dang K and Myers KA: The role of
hypoxia-induced miR-210 in cancer progression. Int J Mol Sci.
16:6353–6372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Meng F, Dong B, Li H, Fan D and Ding J:
RNAi-mediated inhibition of Raf-1 leads to decreased angiogenesis
and tumor growth in gastric cancer. Cancer Biol Ther. 8:174–179.
2009. View Article : Google Scholar
|
